165 related articles for article (PubMed ID: 1284096)
1. [Comparative sensitivity of different solid-phase immunoassays for detecting HBsAg and anti-HCV in blood].
León P; López JA; Domingo CJ; Echevarría JM
Sangre (Barc); 1992 Oct; 37(5):407-10. PubMed ID: 1284096
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of blood centers in the screening of blood donors for viral markers.
Dogbe EE; Arthur F
Pan Afr Med J; 2015; 20():119. PubMed ID: 26090067
[TBL] [Abstract][Full Text] [Related]
3. Screening tests for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus in blood donors: evaluation of two chemiluminescent immunoassay systems.
Sommese L; Sabia C; Paolillo R; Parente D; Capuano M; Iannone C; Cavalca F; Schiano C; Vasco M; De Pascale MR; Casamassimi A; Napoli C
Scand J Infect Dis; 2014 Sep; 46(9):660-4. PubMed ID: 25073538
[TBL] [Abstract][Full Text] [Related]
4. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
Chung HT; Lee JS; Lok AS
Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
[TBL] [Abstract][Full Text] [Related]
5. Are synthetic peptides sensitive enough for screening anti-hepatitis C virus at blood banks?
León P; López JA; Elola C; Domingo CJ; Echevarría JM
Vox Sang; 1994; 67(1):83-4. PubMed ID: 7526551
[No Abstract] [Full Text] [Related]
6. The significance of repeat testing in Turkish blood donors screened with HBV, HCV and HIV immunoassays and the importance of S/CO ratios in the interpretation of HCV/HIV screening test results and as a determinant for further confirmatory testing.
Acar A; Kemahli S; Altunay H; Kosan E; Oncul O; Gorenek L; Cavuslu S
Transfus Med; 2010 Jun; 20(3):152-9. PubMed ID: 20059750
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus transfusion risk in China: proficiency testing for the detection of hepatitis B surface antigen.
Zhang R; Wang L; Li J
Transfus Med; 2010 Oct; 20(5):322-8. PubMed ID: 20409073
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of individual-donation and minipool testing to detect low-level hepatitis B virus DNA in Taiwan.
Yang MH; Li L; Hung YS; Hung CS; Allain JP; Lin KS; Tsai SJ
Transfusion; 2010 Jan; 50(1):65-74. PubMed ID: 19709394
[TBL] [Abstract][Full Text] [Related]
9. [Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors].
Contreras AM; Reta CB; Torres O; Celis A; Domínguez J
Salud Publica Mex; 2011; 53 Suppl 1():S13-8. PubMed ID: 21877067
[TBL] [Abstract][Full Text] [Related]
10. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends.
Singh B; Verma M; Verma K
Jpn J Infect Dis; 2004 Apr; 57(2):49-51. PubMed ID: 15118208
[TBL] [Abstract][Full Text] [Related]
11. Screening test accuracy among potential blood donors of HBsAg, anti-HBc and anti-HCV to detect hepatitis B and C virus infection in rural Cambodia and Vietnam.
Bjoerkvoll B; Viet L; Ol HS; Lan NT; Sothy S; Hoel H; Gutteberg T; Husebekk A; Larsen S; Husum H
Southeast Asian J Trop Med Public Health; 2010 Sep; 41(5):1127-35. PubMed ID: 21073033
[TBL] [Abstract][Full Text] [Related]
12. [Post-transfusional hepatitis].
González A; Esteban JI
Sangre (Barc); 1993 Jun; 38(3):193-200. PubMed ID: 7692610
[No Abstract] [Full Text] [Related]
13. [Hepatitis B and C serologic markers in blood donors of the Ribeirão Preto Blood Center].
Valente VB; Covas DT; Passos AD
Rev Soc Bras Med Trop; 2005; 38(6):488-92. PubMed ID: 16410924
[TBL] [Abstract][Full Text] [Related]
14. Major risk of blood transfusion in hemolytic anemia patients.
Omar N; Salama K; Adolf S; El-Saeed GS; Abdel Ghaffar N; Ezzat N
Blood Coagul Fibrinolysis; 2011 Jun; 22(4):280-4. PubMed ID: 21508832
[TBL] [Abstract][Full Text] [Related]
15. [Viral hepatitis and blood transfusion].
Larsen J; Hetland G; Skaug K; Maeland A
Tidsskr Nor Laegeforen; 1991 Mar; 111(7):825-8. PubMed ID: 1850559
[TBL] [Abstract][Full Text] [Related]
16. [A comparative analysis of blood donors with antibodies to the hepatitis C virus, positivity for the hepatitis B surface antigen and hypertransaminasemia in Asturias].
Suárez A; Riestra S; Rodríguez M; Linares A; Otero L; Rodrigo L
Med Clin (Barc); 1994 Jul; 103(6):209-13. PubMed ID: 7967864
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of third generation anti-HCV enzyme immunoassays.
Panigrahi AK; Nayak B; Dixit R; Acharya SK; Panda SK
Trop Gastroenterol; 1998; 19(3):105-7. PubMed ID: 9828708
[TBL] [Abstract][Full Text] [Related]
18. Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C.
MMWR Recomm Rep; 1991 Apr; 40(RR-4):1-17. PubMed ID: 1850496
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays.
Aach RD; Stevens CE; Hollinger FB; Mosley JW; Peterson DA; Taylor PE; Johnson RG; Barbosa LH; Nemo GJ
N Engl J Med; 1991 Nov; 325(19):1325-9. PubMed ID: 1656258
[TBL] [Abstract][Full Text] [Related]
20. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
Busch MP
Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
